| Health topic | Child mortality |
|---|---|
| Classification | Treatment |
| Scope | Clinical trial |
| Manufacturer location |
California, United States |
Twelve percent of newborns need to receive immediate treatment for severe jaundice. This problem can be solved through the use of phototherapy treatment, but in low-income settings existing phototherapy options are often ineffective, costly, difficult to maintain, and improperly used.
Comet is a low-cost, high-performance, and compact jaundice treatment device intended to be used in rural clinics or as a backup for urban hospitals. This device is a cheaper, smaller and more energy-efficient device than Brilliance, another phototherapy device developed by the same design team. Comet utilizes high intensity light-emitting diodes (LEDs) which provide the intense blue light to treat jaundice. Comet has a lifespan of 3-5 years, requires minimal maintenance, and is designed to retail at less than $150.
India and Nepal
Finalist in Saving Lives at Birth Competition One Heart World-Wide
Hong, M. (2013, October 07). [Web log post]. Retrieved from http://web.archive.org/web/20140210002449/http://blog.d-rev.org:80/
Cheaper, greener blue light: A better phototherapy device for jaundice treatment. Retrieved from https://www.engineeringforchange.org/news/2011/02/01/cheaper_greener_blue_light_a_better_phototherapy_device_for_jaundice_treatment.html
Comet: Effective, compact, and low-cost phototherapy to treat newborn jaundice. (August 8, 2012). Retrieved from http://web.archive.org/web/20160507210939/https://savinglivesatbirth.net/summaries/163
| Authors | Lonny Grafman, Chris Waterguy, Emilio, Kathleen Sienko, Amir Sabet Sarvestani |
|---|---|
| License | CC-BY-SA-3.0 |
| Organizations | Appropedia Foundation, University of Michigan |
| Cite as | Csoyars (2013–2026). "Global Health Medical Device Compendium/Comet". Appropedia. Retrieved September 30, 2026. |